Ostatní
Návod 
Amphastar Pharmaceuticals, Inc.
AMPH
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.2B
Obrat
1B
Zisk
0B
Aktiva
2B
Dluh
1B
ROE
14%
ROA
7%
PE
9
PS
1
Cena 1R
20-38
⌀ Cena
25.57
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Biofarmaceutická společnost Amphastar Pharmaceuticals, Inc. vyvíjí, vyrábí, prodává a prodává generické a proprietární injekční, inhalační a intranazální přípravky ve Spojených státech, Číně a Francii. Společnost působí ve dvou segmentech, Finished Pharmaceutical Products a API. Nabízí přípravek Primatene Mist, volně prodejný inhalační přípravek pro adrenokardiální adrenalin určený k dočasné úlevě od mírných příznaků intermitentního astmatu; Enoxaparin, nízkomolekulární heparin určený k prevenci a léčbě hluboké žilní trombózy; Naloxon určený k předávkování opiáty; Glukagon pro přípravu injekčního roztoku; a Cortrosyn, lyofilizovaný prášek pro použití jako diagnostické léčivo při screeningu pacientů s adrenokortální nedostatečností. Společnost rovněž poskytuje přípravek Amphadase, injekci hyaluronidázy pocházející z hovězího dobytka pro absorpci a disperzi dalších injekčně podávaných léků; injekci epinefrinu pro urgentní léčbu alergických reakcí; želé lidokainu, anestetikum pro urologické procedury; lokální roztok lidokainu pro různé procedury; injekci fytonadionu, injekci vitaminu K1 pro novorozence; přípravky pro nouzové použití v nemocničním prostředí; injekci morfinu pro použití s analgetickými pumpami kontrolovanými pacienty; a injekci lorazepamu pro chirurgické a lékařské procedury. Kromě toho nabízí injekci neostigmin-methylsulfátu k léčbě myasthenia gravis a ke zvrácení účinků svalových relaxancií; a injekci isoproterenol-hydrochloridu k mírným nebo přechodným epizodám srdečního bloku. Dále společnost distribuuje rekombinantní humánní inzulin aktivní farmaceutické složky (API) a inzulin API pro prasata. Slouží nemocnicím, pečovatelským zařízením, místům náhradní péče, klinikám a ordinacím lékařů. Společnost byla založena v roce 1996 a sídlí v Rancho Cucamonga v Kalifornii.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
2028
Založení
2014-06-25
Podobné společnosti
$ 11.19
+ $ 0.36
$ 42.56
+ $ 0.26
$ 22.18
+ $ 0.13
$ 5.23
+ $ 0.02
$ 13.69
- $ 0.11
$ 34.87
+ $ 0.94
$ 15.95
+ $ 0.91
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 719.9 | 719.9 | 732.0 | 644.4 | 499.0 | 437.8 | 349.8 | 322.4 | 294.7 | 240.2 | 255.2 | 251.5 | 210.5 | 229.7 | 204.3 | 118.4 | |
| Cost of Revenues | 363.8 | 363.8 | 358.1 | 293.3 | 250.1 | 238.0 | 206.5 | 190.4 | 187.7 | 149.4 | 151.0 | 174.2 | 159.2 | 142.7 | 114.0 | 90.3 | |
| Gross Profit | 356.1 | 356.1 | 373.9 | 351.1 | 248.9 | 199.7 | 143.3 | 131.9 | 107.0 | 90.8 | 104.2 | 77.3 | 51.3 | 87.0 | 90.3 | 28.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 183.1 | 191.8 | 174.4 | 170.5 | 186.5 | 188.8 | 182.4 | 171.8 | 178.1 | 180.6 | |
| Cost of Revenues | 97.4 | 93.2 | 87.9 | 85.3 | 99.9 | 86.9 | 87.2 | 84.5 | 84.5 | 72.2 | |
| Gross Profit | 85.7 | 98.6 | 86.5 | 85.3 | 86.6 | 101.9 | 95.2 | 87.3 | 93.6 | 108.4 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 73.7 | 74.8 | 60.9 | 67.2 | 68.9 | 57.6 | 43.4 | 41.2 | 37.1 | 28.4 | 33.0 | 31.2 | 31.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 80.4 | 66.6 | 68.9 | 65.2 | 63.1 | 58.0 | 50.9 | 47.3 | 47.0 | 40.4 | 36.3 | 31.6 | 30.5 | |
| Depreciation & Amortization | 45.6 | 0.0 | 57.2 | 41.8 | 28.7 | 26.8 | 25.2 | 21.1 | 16.5 | 15.4 | 14.6 | 13.3 | 14.4 | 13.1 | 11.5 | 11.2 | |
| Total Operating Expenses | 215.7 | 215.7 | 168.4 | 154.1 | 141.4 | 129.9 | 132.4 | 132.0 | 115.6 | 94.3 | 88.5 | 84.0 | 68.8 | 69.3 | 62.8 | 61.6 | |
| Operating Income | 140.4 | 140.4 | 205.4 | 197.0 | 78.8 | 43.1 | -14.2 | 0.0 | -8.6 | -0.9 | 15.7 | -6.9 | -18.0 | 17.5 | 25.4 | -33.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.8 | 16.7 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.7 | 19.1 | ||
| Depreciation & Amortization | 0.0 | 14.1 | 16.2 | 15.2 | 14.7 | 14.4 | 14.1 | 14.0 | 13.8 | 13.6 | ||
| Total Operating Expenses | 50.1 | 73.3 | 44.3 | 48.0 | 41.5 | 44.9 | 39.9 | 39.3 | 39.6 | 35.7 | ||
| Operating Income | 35.6 | 25.3 | 42.2 | 37.3 | 45.1 | 57.0 | 55.2 | 48.0 | 54.0 | 72.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 8.7 | 8.7 | 10.6 | 5.5 | 1.3 | 0.6 | 0.6 | 1.0 | 0.5 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | |
| Interest Expense | 25.5 | 25.5 | 30.3 | 27.2 | 1.8 | 0.9 | 0.4 | 0.1 | 0.2 | 0.8 | 1.0 | 1.0 | 0.6 | 1.0 | 0.8 | 0.6 | |
| Other Expense | -16.8 | -16.8 | -16.2 | -25.6 | 37.3 | 41.0 | 18.9 | 60.3 | -1.3 | 5.2 | -0.7 | -3.0 | -0.6 | 0.4 | -1.1 | 1.8 | |
| IBT | 123.6 | 123.6 | 189.2 | 171.4 | 116.0 | 84.1 | 4.6 | 60.2 | -9.9 | 1.6 | 14.9 | -10.4 | -18.1 | 17.2 | 25.9 | -31.9 | |
| Income Tax Expense | 25.5 | 25.5 | 29.7 | 31.8 | 23.5 | 20.6 | 3.5 | 13.7 | -3.3 | -2.9 | 4.4 | -7.6 | -7.4 | 5.4 | 7.8 | -39.6 | |
| Net Income | 98.1 | 98.1 | 159.5 | 137.5 | 91.4 | 62.1 | 1.1 | 48.9 | -5.7 | 4.5 | 10.5 | -2.8 | -10.7 | 11.9 | 18.1 | 7.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.4 | 2.2 | 1.9 | 2.1 | 2.3 | 2.4 | 3.3 | 2.6 | 2.3 | 1.2 | ||
| Interest Expense | 6.6 | 6.3 | 6.3 | 6.3 | 6.4 | 6.7 | 8.6 | 8.6 | 9.5 | 13.7 | ||
| Other Expense | -3.7 | -3.8 | -2.8 | -6.4 | -1.2 | -9.4 | -5.0 | -0.7 | -12.6 | -9.0 | ||
| IBT | 31.9 | 21.5 | 39.3 | 30.9 | 44.0 | 47.7 | 50.2 | 47.3 | 41.3 | 63.6 | ||
| Income Tax Expense | 7.5 | 4.2 | 8.3 | 5.6 | 6.0 | 7.3 | 12.3 | 4.1 | 4.7 | 14.0 | ||
| Net Income | 24.4 | 17.4 | 31.0 | 25.3 | 38.0 | 40.4 | 37.9 | 43.2 | 36.2 | 49.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $2.85 | $1.88 | $1.30 | $0.02 | $1.04 | $-0.12 | $0.10 | $0.23 | $-0.06 | $-0.25 | $1.48 | $2.26 | $0.97 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $2.60 | $1.74 | $1.25 | $0.02 | $0.98 | $-0.12 | $0.09 | $0.22 | $-0.06 | $-0.25 | $1.48 | $2.26 | $0.97 | |
| Shares Outstanding | 45.9 | 46.7 | 48.4 | 48.3 | 48.6 | 47.8 | 47.0 | 47.0 | 46.4 | 46.1 | 45.4 | 45.0 | 42.0 | 8.0 | 8.0 | 8.0 | |
| Diluted Shares Outstanding | 47.2 | 48.2 | 52.1 | 53.0 | 52.4 | 49.8 | 49.1 | 49.9 | 46.4 | 48.4 | 47.5 | 45.0 | 42.0 | 8.0 | 8.0 | 8.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.75 | $1.01 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.68 | $0.91 | ||
| Shares Outstanding | 45.9 | 46.5 | 46.9 | 47.6 | 48.4 | 48.6 | 48.9 | 48.2 | 48.0 | 48.7 | ||
| Diluted Shares Outstanding | 47.2 | 47.7 | 48.1 | 49.9 | 52.1 | 51.9 | 52.0 | 53.0 | 53.0 | 53.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 189.9 | 151.6 | 144.3 | 156.1 | 126.4 | 92.6 | 73.7 | 86.3 | 65.6 | 72.4 | 66.1 | 67.8 | 53.6 | 50.2 | |
| Short Term Investments | 30.4 | 70.0 | 112.5 | 19.7 | 10.3 | 13.0 | 11.7 | 2.8 | 2.6 | 0.5 | 1.3 | 1.5 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 220.2 | 221.6 | 256.8 | 175.8 | 136.7 | 105.6 | 85.4 | 89.2 | 68.2 | 72.9 | 66.1 | 67.8 | 53.6 | 50.2 | |
| Accounts Receivable | 131.4 | 138.0 | 114.9 | 89.0 | 78.9 | 66.4 | 45.7 | 52.2 | 42.0 | 26.8 | 33.5 | 23.1 | 27.0 | 38.3 | |
| Inventory | 122.4 | 153.7 | 105.8 | 103.6 | 92.8 | 96.8 | 110.5 | 69.3 | 63.6 | 79.8 | 70.7 | 82.3 | 69.9 | 51.4 | |
| Other Current Assets | 8.6 | 20.6 | 12.0 | 7.6 | 7.3 | 6.8 | 9.5 | 5.5 | 9.8 | 3.3 | 4.4 | 3.7 | 5.0 | 3.6 | |
| Total Current Assets | 482.6 | 534.1 | 489.6 | 378.3 | 318.1 | 279.7 | 255.2 | 220.3 | 187.8 | 184.1 | 175.9 | 198.0 | 173.0 | 165.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 216.5 | 187.7 | 182.8 | 151.6 | 192.1 | 189.6 | 201.1 | 144.5 | 266.8 | 148.6 | |
| Short Term Investments | 62.1 | 44.1 | 54.1 | 70.0 | 58.4 | 28.2 | 88.4 | 114.7 | 33.1 | 14.5 | |
| Total Cash & ST Investments | 278.6 | 231.8 | 236.9 | 221.6 | 250.5 | 217.8 | 289.6 | 259.2 | 299.9 | 163.1 | |
| Accounts Receivable | 146.8 | 134.6 | 145.4 | 138.0 | 145.0 | 132.1 | 138.9 | 114.9 | 119.0 | 104.7 | |
| Inventory | 185.9 | 191.7 | 185.5 | 153.7 | 130.3 | 122.4 | 115.5 | 105.8 | 110.0 | 104.6 | |
| Other Current Assets | 28.1 | 22.8 | 20.2 | 20.6 | 20.2 | 10.4 | 11.1 | 21.1 | 20.4 | 18.0 | |
| Total Current Assets | 639.5 | 580.8 | 588.0 | 534.1 | 545.9 | 482.6 | 555.1 | 489.6 | 543.0 | 384.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 320.6 | 344.6 | 315.6 | 264.6 | 271.5 | 280.7 | 253.5 | 210.4 | 185.3 | 152.9 | 142.2 | 138.3 | 116.6 | 107.4 | |
| Goodwill | 3.1 | 3.0 | 3.2 | 3.1 | 3.3 | 3.9 | 3.6 | 4.0 | 4.5 | 4.0 | 3.7 | 4.5 | 0.3 | 0.3 | |
| Intangible Assets | 597.7 | 587.6 | 610.1 | 34.2 | 35.6 | 36.7 | 37.5 | 38.3 | 40.7 | 46.3 | 36.2 | 38.1 | 39.9 | 42.1 | |
| Long-Term Investments | 9.9 | 11.0 | 15.2 | 2.4 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 24.3 | 26.0 | 25.9 | 20.9 | 16.7 | 5.3 | 11.2 | 9.9 | 8.7 | 9.4 | 4.7 | 3.6 | 2.9 | 2.0 | |
| Total Long-Term Assets | 1,008.9 | 1,043.4 | 1,023.3 | 363.7 | 353.4 | 351.6 | 331.7 | 293.2 | 266.9 | 243.6 | 214.2 | 191.4 | 165.8 | 151.8 | |
| Total Assets | 1,491.5 | 1,577.5 | 1,512.9 | 742.0 | 671.5 | 631.2 | 587.0 | 513.6 | 454.7 | 427.7 | 390.1 | 389.4 | 338.7 | 317.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 353.5 | 354.7 | 353.8 | 344.6 | 327.5 | 320.6 | 320.4 | 315.6 | 314.1 | 305.5 | |
| Goodwill | 3.4 | 3.4 | 3.2 | 3.0 | 3.3 | 3.1 | 3.2 | 3.2 | 3.1 | 3.2 | |
| Intangible Assets | 568.8 | 575.1 | 581.4 | 587.6 | 591.5 | 597.7 | 603.9 | 610.1 | 616.3 | 622.4 | |
| Long-Term Investments | 0.0 | 2.0 | 5.9 | 11.0 | 0.0 | 9.9 | 15.2 | 15.2 | 2.0 | 1.5 | |
| Other Long-Term Assets | 29.9 | 28.1 | 23.0 | 26.0 | 23.7 | 24.3 | 23.4 | 25.9 | 25.3 | 20.3 | |
| Total Long-Term Assets | 1,026.8 | 1,034.5 | 1,038.3 | 1,043.4 | 999.2 | 1,008.9 | 1,019.2 | 1,023.3 | 1,001.6 | 993.7 | |
| Total Assets | 1,666.2 | 1,615.3 | 1,626.3 | 1,577.5 | 1,545.2 | 1,491.5 | 1,574.3 | 1,512.9 | 1,544.6 | 1,378.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 31.8 | 30.5 | 25.4 | 84.2 | 89.5 | 95.5 | 77.1 | 87.4 | 16.6 | 16.2 | 13.9 | 10.2 | 20.4 | 17.7 | |
| Short-Term Debt | 4.2 | 7.0 | 8.2 | 6.0 | 5.2 | 15.6 | 10.9 | 18.2 | 6.3 | 5.4 | 10.9 | 7.6 | 22.1 | 22.1 | |
| Other Current Liabilities | 104.9 | 126.5 | 190.1 | 4.6 | 9.1 | 1.1 | 2.0 | 57.3 | 44.3 | 39.0 | 34.5 | 30.8 | 22.3 | 19.7 | |
| Current Liabilities | 137.0 | 173.8 | 225.4 | 94.9 | 103.8 | 112.2 | 90.0 | 106.8 | 67.2 | 60.6 | 60.0 | 62.6 | 65.4 | 60.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 40.5 | 41.9 | 52.8 | 30.5 | 34.1 | 31.8 | 36.5 | 25.4 | 32.0 | 18.8 | |
| Short-Term Debt | 8.8 | 8.8 | 8.0 | 7.0 | 4.5 | 4.2 | 4.4 | 8.2 | 7.9 | 19.2 | |
| Other Current Liabilities | 155.9 | 124.7 | 123.1 | 126.5 | 119.2 | 99.4 | 208.4 | 190.1 | 187.0 | 195.6 | |
| Current Liabilities | 205.2 | 176.4 | 199.1 | 173.8 | 159.0 | 137.0 | 255.2 | 225.4 | 258.0 | 251.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 586.9 | 643.5 | 619.3 | 96.5 | 99.5 | 51.7 | 55.7 | 32.0 | 40.8 | 32.4 | 30.2 | 36.1 | 10.1 | 16.0 | |
| Capital Leases | 29.5 | 48.7 | 33.6 | 26.7 | 27.7 | 20.8 | 19.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 6.1 | 7.0 | 0.0 | 7.4 | 7.1 | 5.5 | 4.3 | 1.4 | 2.2 | 2.3 | 0.5 | 6.3 | 7.2 | 3.2 | |
| Total Liabilities | 778.2 | 845.2 | 873.5 | 213.3 | 226.0 | 182.5 | 159.4 | 149.2 | 117.3 | 98.5 | 94.6 | 107.5 | 87.2 | 84.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 648.0 | 646.7 | 644.6 | 643.5 | 625.4 | 616.3 | 622.7 | 619.3 | 668.4 | 512.7 | |
| Capital Leases | 0.0 | 46.8 | 48.5 | 48.7 | 33.2 | 33.5 | 32.7 | 30.1 | 33.9 | 27.5 | |
| Def. Tax Liability | 0.0 | 7.0 | 7.0 | 7.0 | 6.1 | 6.1 | 6.1 | 6.1 | 7.4 | 7.4 | |
| Total Liabilities | 889.5 | 857.9 | 875.0 | 845.2 | 817.5 | 778.2 | 902.0 | 873.5 | 949.5 | 789.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 490.4 | 568.8 | 409.3 | 271.7 | 180.3 | 117.8 | 116.4 | 67.5 | 76.2 | 70.9 | 60.3 | 63.1 | 73.8 | 61.9 | |
| Comprehensive Income | -8.8 | -9.2 | -8.5 | -8.6 | -6.8 | -3.7 | -4.7 | -4.0 | -2.1 | -4.7 | -2.5 | -1.7 | 0.0 | 0.0 | |
| Total Common Equity | 713.3 | 732.3 | 639.4 | 528.7 | 445.5 | 402.3 | 381.4 | 332.4 | 337.3 | 329.3 | 295.5 | 281.9 | 251.5 | 233.4 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | 642.5 | 625.1 | 594.1 | 568.8 | 530.8 | 490.4 | 452.4 | 409.3 | 373.1 | 323.9 | |
| Comprehensive Income | -5.3 | -5.4 | -8.0 | -9.2 | -8.8 | -8.8 | -8.8 | -8.5 | -8.4 | -8.3 | |
| Total Common Equity | 776.7 | 757.5 | 751.3 | 732.3 | 727.7 | 713.3 | 672.4 | 639.4 | 595.1 | 589.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 620.6 | 650.5 | 623.6 | 102.6 | 104.7 | 67.3 | 66.6 | 50.2 | 47.2 | 37.7 | 41.1 | 43.7 | 32.2 | 38.0 | |
| Book Value | 713.3 | 732.3 | 639.4 | 528.7 | 445.5 | 448.7 | 427.5 | 364.4 | 337.3 | 329.3 | 295.5 | 281.9 | 251.5 | 233.4 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 776.7 | 757.5 | 751.3 | 732.3 | 727.7 | 713.3 | 672.4 | 639.4 | 595.1 | 589.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 166.5 | 98.1 | 159.5 | 137.5 | 91.4 | 63.3 | 1.1 | 46.5 | -6.7 | 4.5 | 10.5 | -2.8 | -10.7 | 11.9 | 18.1 | 7.8 | |
| Depreciation & Amortization | 55.5 | 63.2 | 57.2 | 41.8 | 28.7 | 26.8 | 25.2 | 21.1 | 16.5 | 15.4 | 14.6 | 13.3 | 14.4 | 13.1 | 11.5 | 11.2 | |
| Stock-Based Compensation | 22.4 | 27.3 | 24.4 | 20.2 | 17.9 | 18.7 | 20.5 | 17.3 | 16.7 | 17.1 | 15.1 | 12.8 | 9.3 | 7.0 | 7.4 | 8.0 | |
| Change Working Capital | -31.1 | -66.0 | -14.5 | -24.2 | -32.2 | -1.9 | 9.1 | -51.7 | 12.1 | 0.6 | 0.3 | -5.1 | 15.6 | -3.2 | -49.6 | 27.6 | |
| Change In Accounts Receivable | -32.1 | -6.4 | -21.7 | -26.1 | -10.1 | -14.9 | -20.2 | 6.7 | -16.3 | -8.1 | 6.4 | -11.0 | 1.2 | 11.8 | -16.6 | -1.2 | |
| Change In Accounts Payable | 39.9 | -4.6 | 63.6 | 13.2 | -0.7 | 3.0 | 15.0 | -17.9 | 29.2 | 6.7 | -0.8 | -3.1 | 5.5 | 4.2 | -8.0 | 20.8 | |
| Change In Inventories | -18.0 | -21.1 | -48.8 | -1.7 | -11.7 | 1.3 | 15.3 | -41.1 | -6.0 | 18.7 | -9.7 | 9.8 | 6.6 | -18.5 | -25.2 | -1.9 | |
| Other Non-cash Items | 80.6 | 5.9 | 4.7 | 20.7 | -0.9 | -13.0 | 0.2 | 1.0 | 1.4 | -2.3 | 1.3 | 0.4 | 0.6 | 0.2 | 2.7 | 0.6 | |
| Cash from Operations | 212.6 | 0.0 | 0.0 | 183.5 | 89.2 | 98.0 | 57.3 | 41.8 | 38.2 | 39.2 | 38.6 | 10.7 | 21.1 | 31.0 | -1.7 | 19.1 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 24.4 | 17.4 | 31.0 | 25.3 | 38.0 | 40.4 | 37.9 | 43.2 | 36.2 | 49.2 | |
| Depreciation & Amortization | 16.0 | 14.1 | 13.0 | 15.2 | 14.7 | -4.1 | 14.1 | 14.0 | 13.8 | 13.6 | |
| Stock-Based Compensation | 6.2 | 6.3 | 6.4 | 8.4 | 5.6 | 5.6 | 5.8 | 7.4 | 4.6 | 4.6 | |
| Change Working Capital | -42.7 | 12.0 | -18.5 | -16.7 | -8.6 | -7.3 | 8.6 | -7.3 | -26.7 | -5.7 | |
| Change In Accounts Receivable | 3.2 | -13.8 | 12.3 | -8.1 | 2.9 | -8.1 | 6.7 | -23.2 | 4.1 | -19.6 | |
| Change In Accounts Payable | -42.6 | 25.3 | -4.9 | 17.6 | 2.1 | 24.6 | 13.7 | 23.1 | -3.4 | 6.5 | |
| Change In Inventories | 9.0 | 5.9 | -4.8 | -31.1 | -24.5 | -7.3 | -7.0 | -10.0 | 4.8 | -5.8 | |
| Other Non-cash Items | 29.0 | 2.8 | 3.7 | 2.9 | -20.6 | 25.4 | 2.6 | -1.9 | 8.6 | 5.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.9 | 64.3 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -34.5 | -34.9 | -41.0 | -38.2 | -24.0 | -27.5 | -33.9 | -41.6 | -46.8 | -35.1 | -21.4 | -16.0 | -20.5 | -18.3 | -25.2 | -10.7 | |
| Acquisitions | 371.8 | 0.0 | -129.0 | -506.4 | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 | 2.0 | -12.5 | 0.0 | -18.4 | 0.0 | 0.0 | 0.0 | |
| Investments | -146.3 | -119.1 | -76.8 | -144.6 | -35.8 | -17.4 | -13.6 | -8.8 | -0.3 | -5.6 | -3.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 126.7 | 90.3 | 126.0 | 38.6 | 28.0 | 18.8 | 12.4 | 0.0 | 0.1 | 3.7 | 3.1 | 0.0 | 0.0 | 0.5 | 0.8 | 0.2 | |
| Other Investing Activities | 0.7 | 0.0 | 0.0 | 1.4 | -1.0 | -2.6 | -1.4 | -0.2 | 0.2 | -3.7 | -5.1 | -0.9 | -0.9 | -0.5 | -0.7 | 0.0 | |
| Cash from Investing | -188.9 | 0.0 | 0.0 | -649.1 | -32.8 | -28.7 | -36.4 | -50.5 | -42.2 | -38.8 | -39.5 | -16.9 | -39.8 | -18.3 | -25.1 | -10.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -8.3 | -5.3 | -10.6 | -10.7 | -12.4 | -13.8 | -6.0 | -8.8 | -9.4 | -10.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 129.0 | -129.0 | 0.0 | 506.4 | -5.6 | |
| Investments | -68.3 | -35.2 | -8.5 | -7.1 | -29.3 | -26.0 | 1.0 | -22.5 | -91.8 | -33.0 | |
| Sales of Investment | 16.4 | 22.5 | 23.0 | 28.3 | 7.5 | 5.3 | 65.8 | 47.5 | -0.2 | 13.7 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.7 | 4.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -103.0 | -31.2 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -196.9 | 0.0 | 0.0 | 526.3 | -1.8 | -37.9 | -8.4 | -6.8 | -5.7 | -9.7 | -14.7 | -9.0 | -54.2 | -73.2 | -30.1 | -5.9 | |
| Debt Issued | 288.7 | 650.5 | 26.9 | 1,047.4 | -0.3 | 75.3 | 9.0 | 23.2 | 8.8 | 19.1 | 11.3 | 6.4 | 65.7 | 67.3 | 68.1 | 5.9 | |
| Issuance of Common Stock | -5.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.3 | 38.0 | 13.8 | 20.6 | 1.3 | 38.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -17.7 | -75.6 | -85.5 | -58.1 | -39.9 | -28.9 | -24.4 | -22.3 | -25.0 | -30.7 | -9.9 | -10.5 | -0.7 | -0.2 | -0.8 | -1.8 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -20.3 | 0.0 | -10.2 | -20.3 | -52.1 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -11.2 | 0.0 | 0.0 | -14.1 | 15.3 | 29.8 | 30.6 | 7.0 | 38.0 | 19.0 | 21.3 | 40.7 | 101.1 | 64.0 | 54.2 | -0.9 | |
| Cash from Financing | 15.2 | 0.0 | 0.0 | 454.1 | -26.4 | -37.0 | -2.2 | -3.8 | 25.0 | -7.7 | 7.1 | 2.2 | 32.1 | -9.4 | 23.2 | -8.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -50.2 | 144.9 | |
| Debt Issued | 656.8 | 1.3 | 3.0 | 2.0 | 20.7 | 9.3 | -6.5 | 3.5 | 1.2 | 288.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 0.0 | |
| Repurchase of Common Stock | -20.5 | 50.2 | -39.2 | -11.0 | -42.0 | -35.0 | -8.5 | -17.3 | 58.1 | -50.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.1 | -8.3 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -47.1 | 86.6 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 38.6 | 18.6 | 7.3 | -11.8 | 29.7 | 32.1 | 19.0 | -12.7 | 20.7 | -6.8 | 6.3 | -1.8 | 14.2 | 3.4 | -3.5 | 0.0 | |
| Closing Cash Balance | 189.9 | 170.4 | 151.8 | 144.5 | 156.3 | 126.6 | 94.5 | 75.6 | 88.2 | 65.6 | 72.4 | 66.1 | 67.8 | 53.6 | 50.2 | 53.7 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -46.1 | 28.6 | 4.9 | 31.2 | -40.5 | 2.5 | -11.5 | 56.9 | -126.5 | 119.8 | |
| Closing Cash Balance | 170.4 | 216.5 | 187.9 | 183.0 | 151.8 | 192.4 | 189.9 | 201.4 | 144.5 | 271.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 178.1 | 121.2 | 172.3 | 145.3 | 65.1 | 70.5 | 23.4 | 0.2 | -8.6 | 4.1 | 17.2 | -5.4 | 0.6 | 12.7 | -26.9 | 8.4 | |
| Real Free Cash Flow | 155.7 | 94.0 | 148.0 | 125.1 | 47.3 | 51.9 | 2.9 | -17.1 | -25.3 | -13.0 | 2.1 | -18.2 | -8.7 | 5.7 | -34.3 | 0.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 24.6 | 47.2 | 25.0 | 24.4 | 16.6 | 46.2 | 63.1 | 46.5 | 14.4 | 54.1 | |
| Real Free Cash Flow | 18.4 | 40.9 | 18.6 | 16.0 | 11.0 | 40.6 | 57.3 | 39.1 | 9.8 | 49.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 9.4 | 139.4 | 2356.8 |
| P/S | 1.3 | 3 | 70.5 |
| P/B | 1.2 | 2.5 | 2015.4 |
| P/FCF | 9.8 | -2.9 | 7573.5 |
| Market cap | $1.2 | $1.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 39.4 % | 15 % | 0 % |
| Debt to Income | 669.5 % | 743.5 % | 0 % |
| Debt to Free cash flow | 699 % | 3.7 % | 0 % |
| Interest expense percentage | 18.1 % | 135.2 % | 26.2 % |
| Current ratio | 3.1 | 2.6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 12.6 % | 6.8 % | 0 % |
| ROA | 5.9 % | 3.8 % | 0 % |
| CapEx to Revenue | 5.4 % | 8.9 % | 6 % |
| RaD to Revenue | 0 % | 15.2 % | 0 % |
| ROEM | 354,973.9 | 824095.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 49.4 % | 41 % | 74.8 % |
| Operating margin | 20.7 % | 8.3 % | 35 % |
| Net margin | 15.4 % | 8 % | 34.1 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1.2 % | 0 % |
| Dividend payout percentage | 0 % | 151.7 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 47.7 mil | 45.5 mil |
| Employee count | 2.0 tis | 1.8 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
